Free Trial

Ryan Specialty (RYAN) Expected to Announce Quarterly Earnings on Thursday

Ryan Specialty logo with Finance background

Ryan Specialty (NYSE:RYAN - Get Free Report) is projected to release its Q1 2025 earnings data after the market closes on Thursday, May 1st. Analysts expect the company to announce earnings of $0.40 per share and revenue of $680.80 million for the quarter.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, analysts expect Ryan Specialty to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Ryan Specialty Trading Down 6.8 %

Shares of Ryan Specialty stock traded down $4.71 on Friday, hitting $64.87. The stock had a trading volume of 2,281,713 shares, compared to its average volume of 960,444. The stock has a 50 day moving average of $70.43 and a 200 day moving average of $68.94. The firm has a market capitalization of $16.99 billion, a P/E ratio of 94.02, a PEG ratio of 1.19 and a beta of 0.66. Ryan Specialty has a twelve month low of $48.67 and a twelve month high of $77.16. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty's dividend payout ratio is 69.57%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. UBS Group upped their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. TD Cowen initiated coverage on Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 target price for the company. Barclays cut their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Wells Fargo & Company lowered their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Finally, Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Ryan Specialty has an average rating of "Hold" and an average target price of $75.67.

Get Our Latest Report on Ryan Specialty

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company's stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $65.25, for a total transaction of $2,283,750.00. Following the completion of the sale, the director now directly owns 6,209 shares in the company, valued at $405,137.25. This represents a 84.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold 96,409 shares of company stock worth $6,424,437 over the last ninety days. Insiders own 11.10% of the company's stock.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Earnings History for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines